13S165: Abstracts: RA – Treatment II: Pre- and Early Disease (1603–1607)

Abstract Moderator(s)

• 

  Ted Mikuls, n/a

  Division of Rheumatology, University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System
  Omaha, NE, United States

  Disclosure(s): Gilead: Consultant (Terminated); Horizon: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Terminated); UpToDate: Royalties (Ongoing)
• RH

  Rebecca Haberman, MD

  NYU Langone Health
  New York, NY, United States

  Disclosure(s): No financial relationships to disclose

Oral abstract session.

Presentations:

• 4:30 PM – 4:40 PM Eastern Time

  Intervention with Methotrexate in Arthralgia at Risk for Rheumatoid Arthritis to Reduce the Development of Persistent Arthritis and Its Disease Burden (TREAT EARLIER): A Double-blind, Randomized, Placebo-controlled Trial
  

  Presenting Author: Doortje Krijbolder, MD – Leiden University Medical Center
• 4:40 PM – 4:45 PM Eastern Time

  Q&A
  
• 4:45 PM – 4:55 PM Eastern Time

  Hydroxychloroquine Does Not Prevent the Future Development of Rheumatoid Arthritis in a Population with Baseline High Levels of Antibodies to Citrullinated Protein Antigens and Absence of Inflammatory Arthritis: Interim Analysis of the StopRA Trial
  

  Presenting Author: Kevin D. Deane, MD, PhD – University of Colorado Denver Anschutz Medical Campus
• 4:55 PM – 5:00 PM Eastern Time

  Q&A
  
• 5:00 PM – 5:10 PM Eastern Time

  Profound Anticoagulant Effects of Initial Antirheumatic Treatments in Early Rheumatoid Arthritis Patients; A NORD-STAR Spin-off Study
  

  Presenting Author: Bas Dijkshoorn, MD, MSc – Reade
• 5:10 PM – 5:15 PM Eastern Time

  Q&A
  
• 5:15 PM – 5:25 PM Eastern Time

  An Expanded Anti-citrullinated Protein Antibody Profile Derived Using Unsupervised Machine Learning Predicts Treatment Responses to Biologic Therapies in Rheumatoid Arthritis
  

  Presenting Author: Nozima Aripova, BS – University of Nebraska Medical Center
• 5:25 PM – 5:30 PM Eastern Time

  Q&A
  
• 5:30 PM – 5:40 PM Eastern Time

  Machine Learning Identifies Biomarker of Non-Response to Methotrexate in Rheumatoid Arthritis
  

  Presenting Author: Vincent Bouget, MSc – Scienta Lab
• 5:40 PM – 5:45 PM Eastern Time

  Q&A